A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism

Clinical trial NCT05187377 · COMPLETED

Trial details

NCT number: NCT05187377
Sponsor: Icahn School of Medicine at Mount Sinai
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Phelan-McDermid Syndrome Autism Spectrum Disorder (ASD)

Start date: 2022-01-19
Primary completion: 2025-01-28
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.